RAYNE ROUCE to Lymphoma
This is a "connection" page, showing publications RAYNE ROUCE has written about Lymphoma.
Connection Strength
0.976
-
Are we there yet? The never-ending quest for an Epstein-Barr virus vaccine. J Clin Invest. 2019 04 15; 129(5):1836-1838.
Score: 0.484
-
Differential antibody response to EBV proteome following EBVST immunotherapy in EBV-associated lymphomas. Blood Adv. 2025 Apr 08; 9(7):1658-1669.
Score: 0.183
-
Prolonged cytopenias after immune effector cell therapy and lymphodepletion in patients with leukemia, lymphoma and solid tumors. Cytotherapy. 2024 Sep; 26(9):1026-1032.
Score: 0.172
-
T-Cell Therapy for Lymphoma Using Nonengineered Multiantigen-Targeted T Cells Is Safe and Produces Durable Clinical Effects. J Clin Oncol. 2021 05 01; 39(13):1415-1425.
Score: 0.137